Amble Tirzepatide is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist with significant potential in metabolic research. The compound, also known as LY3298176, represents an important advancement in peptide-based therapeutic research.
The unique mechanism of Amble Tirzepatide involves simultaneous activation of both GIP and GLP-1 receptors, which are key regulators of glucose metabolism and energy homeostasis. This dual action makes it particularly interesting for studying metabolic disorders.
Current research applications of Amble Tirzepatide include:
1. Type 2 Diabetes Studies: Demonstrates superior glucose control compared to single receptor agonists in preclinical models
2. Obesity Research: Shows promising weight reduction effects through multiple metabolic pathways
3. Cardiovascular Protection: Potential cardioprotective properties are under investigation
4. NAFLD/NASH Research: Emerging evidence suggests benefits for non-alcoholic fatty liver disease
Our Amble Tirzepatide is supplied as a white to off-white lyophilized powder with guaranteed 99% purity by HPLC analysis. The product is thoroughly characterized by mass spectrometry and meets strict quality control standards for research use.
Storage conditions: Maintain at -20°C in a dry environment. For long-term storage, keep desiccated at -80°C. The compound should be protected from light and moisture to ensure stability.
Important Note: This product is intended for research purposes only. Not for human or veterinary use.